FiercePharma28d
FDA signs off on Sanofi's insulin biosimilar, the first for Novo Nordisk's rapid-acting NovoLog
More than three years after approving two biosimilars referencing Sanofi’s long-acting insulin Lantus ... prefilled pen in a 3 mL dose or in a multiple-dose 10 mL vial. It is for adults and ...
Business Insider India2y
There's something odd about the way insulin prices change
A 10 ml vial of Sanofi's long-acting insulin Lantus first hit the US market at $34.81 a vial in 2001, according to data from Truven Health Analytics. Since 2014, the last time Sanofi raised the ...
Benzinga.com28d
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Merilog is available in a 3 mL prefilled pen and a 10 mL vial, joining two long-acting ... the price of its best-selling insulin product, Lantus (insulin glargine), by 78%. Sanofi said it would ...